Nature Communications (Apr 2024)

Functional synergy of a human-specific and an ape-specific metabolic regulator in human neocortex development

  • Lei Xing,
  • Vasiliki Gkini,
  • Anni I. Nieminen,
  • Hui-Chao Zhou,
  • Matilde Aquilino,
  • Ronald Naumann,
  • Katrin Reppe,
  • Kohichi Tanaka,
  • Peter Carmeliet,
  • Oskari Heikinheimo,
  • Svante Pääbo,
  • Wieland B. Huttner,
  • Takashi Namba

DOI
https://doi.org/10.1038/s41467-024-47437-8
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Metabolism has recently emerged as a major target of genes implicated in the evolutionary expansion of human neocortex. One such gene is the human-specific gene ARHGAP11B. During human neocortex development, ARHGAP11B increases the abundance of basal radial glia, key progenitors for neocortex expansion, by stimulating glutaminolysis (glutamine-to-glutamate-to-alpha-ketoglutarate) in mitochondria. Here we show that the ape-specific protein GLUD2 (glutamate dehydrogenase 2), which also operates in mitochondria and converts glutamate-to-αKG, enhances ARHGAP11B’s ability to increase basal radial glia abundance. ARHGAP11B + GLUD2 double-transgenic bRG show increased production of aspartate, a metabolite essential for cell proliferation, from glutamate via alpha-ketoglutarate and the TCA cycle. Hence, during human evolution, a human-specific gene exploited the existence of another gene that emerged during ape evolution, to increase, via concerted changes in metabolism, progenitor abundance and neocortex size.